I cannot seem to find many other sources for this story nor can I find a lot of information about Celtura aside from what I have previously posted. Apparently, Novartis was facing hurdles getting Celtura approved by the Swiss, but Novartis denies the claim.
Source: Khaleej Times Online
Swiss pharmaceutical group Novartis on Monday denied that it faced hurdles in gaining regulatory approval in Switzerland for one of its swine flu vaccines because of possible bacterial contamination.
The vaccine, branded as Celtura, is produced by a technique using cell cultures from dog kidneys, allowing more rapid production than by the more classical method using chicken eggs, according to the company.
Citing anonymous sources close to the case, the Swiss daily Tages-Anzeiger reported on Saturday that the Swiss authority overseeing medicines and therapeutical products, Swissmedic, had found bacterial contamination in test batches of Celtura.
Source: Khaleej Times Online
No comments:
Post a Comment